Vascular lesions with telangiectasias on visible areas, such as the face, are common in discoid lupus erythematosus (DLE); however, an efficient management of these skin lesions can sometimes be difficult. Since argon laser light is able to specifically coagulate vascular structures, it has been used in the treatment of various vascular skin malformations. Therefore, we addressed the issue whether argon laser treatment could be a therapeutic alternative for this disease. Here, we report on a patient with DLE, who suffered from long-standing erythematous, telangiectatic plaques on the face refractory to standard regimens of therapy. After 2 laser applications, a significant improvement was observed and after 5 sessions of argon laser therapy the treated skin lesions had completely resolved with an excellent cosmetic result. The patient tolerated the laser treatment well without any short-term side effects. These data indicate that argon laser therapy might be a powerful alternative approach in the treatment of vascular skin lesions of DLE.

Keywords:
Argon laser, Discoid lupus erythematosus, Treatment of cutaneous lupus erythematosus
1.
Sontheimer RD, Provost TT: Lupus erythematosus; in Sontheimer RD, Provost TT (eds): Cutaneous Manifestations of Rheumatic Diseases, ed 1. Baltimore, Williams & Wilkins, 1997, pp 1–71.
2.
Kuhn A, Schuppe HC, Lehmann P, Goerz G, Ruzicka T: Cutaneous manifestations of lupus erythematosus: What is important for rheumatologists? Rheumatol Europe 1998;27:95–101.
3.
Wallace DJ: Antimalarial agents and lupus. Rheum Dis Clin North Am 1994;20:243–263.
4.
Drake LA, Dinehardt SM, Farmer ER, Goltz RW, Graham GF, Hordinsky MK, Lewis CW, Pariser DM, Skouge JW, Webster SB, Whitaker DC, Butler B, Lowery BJ: Guidelines of care for cutaneous lupus erythematosus. J Am Acad Dermatol 1996;34:830–836.
5.
Callen JP: Management of antimalarial-refractory cutaneous lupus erythematosus. Lupus 1997;6:203–208.
6.
Werth VP, Dutz JP, Sontheimer RD: Pathogenetic mechanisms and treatment of cutaneous lupus erythematosus. Curr Opin Rheumatol 1997;9:400–409.
7.
Lo JS, Berg RE, Tomecki KJ: Treatment of discoid lupus erythematosus. Int J Dermatol 1989;28:497–507.
8.
Tappeiner G: Therapie des Lupus erythematodes 1994. Z Hautkr 1994;69:816–822.
9.
Zachariae H, Bjerring P, Cramers M: Argon laser treatment of cutaneous vascular lesions in connective tissue diseases. Acta Derm Venereol 1988;68:179–182.
10.
Lehmann P, Hölzle E, Kind P, Goerz G, Plewig G: Experimental reproduction of skin lesions in lupus erythematosus by UVA and UVB radiation. J Am Acad Dermatol 1990;22:181–187.
11.
Henderson DL, Odom JC: Laser treatment of discoid lupus (case report). Lasers Surg Med 1986;6:12–15.
12.
Nunez M, Boixeda P, Miralles ES, de Misa RF, Ledo A: Pulsed dye laser treatment in lupus erythematosus telangiectoides. Br J Dermatol 1995;133:1010–1011.
13.
Nunez M, Boixeda P, Miralles ES, de Misa RF, Ledo A: Pulsed dye laser treatment of telangiectatic chronic erythema of cutaneous lupus erythematosus. Arch Dermatol 1996;132:354–355.
14.
Nürnberg W, Algermissen B, Hermes B, Henz BM, Kolde G: Erfolgreiche Behandlung des chronisch diskoiden Lupus erythematodes mittels Argon-Laser. Hautarzt 1996;47:767–770.
15.
Raulin C, Schmidt C, Hellwig S: Cutaneous lupus erythematosus – Treatment with pulsed dye laser. Br J Dermatol 1999;141:1046–1050.
16.
Wolfe JT, Weinberg JM, Elenitsas R, Uberti-Benz M: Cutaneous lupus erythematosus following laser-induced thermal injury. Arch Dermatol 1997;133:392–393.
17.
Ueki H: Köbner-Phänomen bei Lupus erythematodes. Hautarzt 1994;45:154–160.
18.
Spicer MS, Goldberg DJ: Lasers in dermatology. J Am Acad Dermatol 1996;34:1–25.
19.
Garden JM, Geronemus RG: Dermatologic laser surgery. J Dermatol Surg Oncol 1990;16:156–168.
20.
Langian SW: A review of the laser treatment of vascular naevi. J Dermatol Treat 1991;2:113–116.
21.
Achauer BM, Vander Kam VM: Argon laser treatment of telangiectasia of the face and the neck: 5 year’s experience. Laser Surg Med 1989;9:495–498.
© 2000 S. Karger AG, Basel
2000
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.